Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 3:9:389-393.
doi: 10.2147/MDER.S107426. eCollection 2016.

Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study

Arthur Roberts  1 , Alec Sithole  2 , Marcos Sedghi  3 , Charles A Walker  4 , Theresa M Quinn  5
Affiliations

Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study

Arthur Roberts et al. Med Devices (Auckl). .

Abstract

The periauricular percutaneous implantation of the Neuro-Stim System™ family of devices EAD, MFS, and BRIDGE is a procedure involving the use of a non-opiate, neuromodulation analgesic for relieving acute and chronic pain. It has been approved as a minimal-risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding, localized dermatitis, and infections at the implantation sites of the electrode/needle arrays, dermatitis at the site of the generator, and patient syncope. A total of 1,207 devices, each producing up to 16 percutaneous punctures, for a total of 19,312 punctures were monitored for adverse effects, based on retrospective chart audits conducted at six clinical facilities over a 1-year period.

Keywords: Bridge; EAD; MFS; Neuro-Stim System™ devices; adverse effects; clinical risks and discomfort; neuromodulation; percutaneous auricular neurostimulation.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Concentration of cranial nerves. Abbreviations: LON, lesser occipital nerve; ABVN, auricular branch of vagus nerve; GAN, great auricular nerve; GON, greater occipital nerve.
Figure 2
Figure 2
Assembled Neuro-Stim System™ device.
Figure 3
Figure 3
Device convenience kit.
Figure 4
Figure 4
Neurovascular bundles isolated by transillumination.
Figure 5
Figure 5
Activated device properly implanted.
See this image and copyright information in PMC

References

    1. Frangos E, Ellrich J, Komisaruk BR. Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain Stimul. 2015;8(3):624–636. - PMC - PubMed
    1. George MS, Nahas Z, Borckardt JJ, et al. Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Exp Rev Neurother. 2007;7(1):1–12. - PubMed
    1. Ghoname EA, Craig WF, White PF, et al. Percutaneous electrical nerve stimulation for low back pain. JAMA. 1999;281(9):818–823. - PubMed
    1. Goadsby PJ, Cohen AS, Matharu MS. Trigeminal autonomic cephalgias: diagnosis and treatment. Curr Neurol Neurosci Rep. 2007;7(2):117–125. - PubMed
    1. Zhang Y, Popovic ZB, Bibevesky S, et al. Chronic vagus stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2(6):692–699. - PubMed

LinkOut - more resources